• Explore /
  • Poster
  • / A phase II/III randomized trial of two doses of MK-3475 versus docetaxel in previously treated subjects with non-small cell lung cancer.

A phase II/III randomized trial of two doses of MK-3475 versus docetaxel in previously treated subjects with non-small cell lung cancer.

Abstract Poster

Authors

null

Roy S. Herbst

Department of Medical Oncology, Yale University School of Medicine, New Haven, CT

Roy S. Herbst , Alfonso Gurpide , Veerle Surmont , Dong-Wan Kim , Saiama Naheed Waqar , Judith Herder , Dae Ho Lee , Enric Carcereny , Noemi Reguart , John M. Wallmark , Suresh S. Ramalingam , Corey J. Langer , Gregory M. Lubiniecki , James Knowles , Honghong Zhou , Mary Elizabeth Hanson , Paul Baas

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer - Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT01905657

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr TPS8124)

DOI

10.1200/jco.2014.32.15_suppl.tps8124

Abstract #

TPS8124

Poster Bd #

302A

Abstract Disclosures

Similar Posters

First Author: Joaquim Bellmunt

First Author: Nikhil Shukla

First Author: Saveri Bhattacharya

First Author: Manish A. Shah